Related News
Merck plans 650m yuan pharma factory in Nantong
Online Edition
PHARMACEUTICAL giant Merck announced a 650 million yuan (US$107 million) investment in a new drug manufacturing facility in Nantong, Jiangsu Province.
“The investment reflects Merck’s long-term commitment to China, where our group has been present for 80 years,” said Belen Garijo, president and CEO of Merck Serono, the biopharmaceutical division of Merck.
The new facility will focus on bulk production and packaging of Merck’s leading brands for the treatment of diabetes, cardiovascular diseases and thyroid disorders.
The construction, which start in 2014, will be completed in 2016.
The new facility will become Merck Serono’s second largest pharmaceutical manufacturing site in the world, the company said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
